Train harder · Free ship $75+ · Gear up now
foxo4-dri peptide senolytic human trial

foxo4-dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis TRANSLATING THE BIOLOGY OF AGING

SKU: 30073354536

4.9
USD26.01 USD63.01

Pay in 4 interest-free payments of $6.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

PMC6073405

foxo4-dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis TRANSLATING THE BIOLOGY OF AGING

GHK-Cu is one of the most extensively researched copper peptides in the field of dermatology and anti-aging science

foxo4-dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis TRANSLATING THE BIOLOGY OF AGING

References and citations RESEARCH CITATIONS [1] Bhatt DL et al

foxo4-dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis TRANSLATING THE BIOLOGY OF AGING

Protects Peptide Stability Peptides are sensitive to pH shifts, oxidation, and bacterial enzymes

foxo4-dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis TRANSLATING THE BIOLOGY OF AGING

Considered a niche peptide with strong interest in sleep and neurological signaling investigations

foxo4-dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis TRANSLATING THE BIOLOGY OF AGING
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products